Talphera Inc... Show more
a developer of innovative therapies for the treatment of acute and breakthrough pain
Industry PharmaceuticalsGeneric
A.I.dvisor tells us that TLPH and TKNO have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLPH and TKNO's prices will move in lockstep.
| Ticker / NAME | Correlation To TLPH | 1D Price Change % | ||
|---|---|---|---|---|
| TLPH | 100% | N/A | ||
| TKNO - TLPH | 24% Poorly correlated | -2.89% | ||
| HROW - TLPH | 24% Poorly correlated | -5.74% | ||
| TXMD - TLPH | 21% Poorly correlated | +2.86% | ||
| ZSTK - TLPH | 21% Poorly correlated | -1.22% | ||
| SIGA - TLPH | 21% Poorly correlated | +0.33% | ||
More | ||||
| Ticker / NAME | Correlation To TLPH | 1D Price Change % |
|---|---|---|
| TLPH | 100% | N/A |
| Pharmaceuticals: Generic industry (84 stocks) | 12% Poorly correlated | -0.05% |
On September 09, 2026, the Stochastic Oscillator for TLPH moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 75 instances where the indicator left the oversold zone. In 68 of the 75 cases the stock moved higher in the following days. This puts the odds of a move higher at over 90%.
The Momentum Indicator moved above the 0 level on September 11, 2026. You may want to consider a long position or call options on TLPH as a result. In 78 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 90%.
The Moving Average Convergence Divergence (MACD) for TLPH just turned positive on September 10, 2026. Looking at past instances where TLPH's MACD turned positive, the stock continued to rise in 39 of 45 cases over the following month. The odds of a continued upward trend are 87%.
Following a +4.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where TLPH advanced for three days, in 180 of 223 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
TLPH moved below its 50-day moving average on August 27, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for TLPH crossed bearishly below the 50-day moving average on August 25, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 75%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TLPH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
TLPH broke above its upper Bollinger Band on August 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. TLPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 89 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.468) is normal, around the industry mean (46.728). P/E Ratio (0.000) is within average values for comparable stocks, (93.360). TLPH's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.931). TLPH has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (1250.000) is also within normal values, averaging (176.516).
The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TLPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.